Two members of U.S. FDA advisory panel resign over Alzheimer's drug approval

  • 📰 Reuters
  • ⏱ Reading Time:
  • 16 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Two members of a panel of outside advisors to the U.S. Food and Drug Administration have resigned in protest at the agency's decision to approve Biogen Inc's (BIIB.O) Aduhelm for treatment of Alzheimer's disease despite the committee’s recommendation against doing so.

A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder

Aduhelm for treatment of Alzheimer's disease despite the committee’s recommendation against doing so. "I was very disappointed at how the advisory committee input was treated by the FDA," Dr. Knopman told Reuters. "I don't wish to be put in a position like this again.”

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

newborn NotaryServices SpainNATO Navy_JAG AF JAG

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Two doctors have resigned from a prestigious panel after FDA approved a controversial Alzheimer's drugBusiness Insider tells the global tech, finance, markets, media, healthcare, and strategy stories you want to know.
Source: BusinessInsider - 🏆 729. / 51 Read more »

FDA Approves First New Alzheimer’s Drug in Nearly Two DecadesThe approval of the Biogen drug, which has the molecular name aducanumab and will be sold as Aduhelm, marked a watershed in Alzheimer’s drug research after billions of dollars in investment. but they forgot where they put it
Source: WSJ - 🏆 98. / 63 Read more »

WSJ News Exclusive | Mystery Buyer Pays $157.5 Million for Two Condos on New York’s Billionaires’ RowTwo condos at New York’s 220 Central Park South have sold for a combined $157.5 million. It is one of the city’s priciest residential transactions of all time. good A NUG leader admits to engaging in terrorist activities  The best choice I've made this year was investing in cryptocurrency and forex trading and earning from home. With the help of micheal33590 I've been earning $ 23k weekly I've never regretted this decision. 🙏🏻🙏🏻
Source: WSJ - 🏆 98. / 63 Read more »

‘BuzzFeed Unsolved’ Final Two Seasons Set to Premiere This Year“BuzzFeed Unsolved,” the long-running online documentary series starring Shane Madej and Ryan Bergara, is coming to an end after five years. The eighth and final season of “BuzzFeed Uns… WHYYYYYYYYYYY It is literally carrying Buzzfeed so hard why would they end it. Final season whyy ?
Source: Variety - 🏆 108. / 63 Read more »

18 Reasons Why You Should Binge-Watch 'Love, Victor' Before Season Two BeginsCan I say just because it’s amazing? lenif18
Source: BuzzFeed - 🏆 730. / 51 Read more »

Two Men, a Highway Robbery, and One Hot Encounter'Percy licked into Kit’s mouth, and that was when Kit realized he wasn’t in charge of this kiss, not in the slightest.'
Source: Jezebel - 🏆 153. / 63 Read more »